Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:47 PM
Ignite Modification Date:
2025-12-24 @ 11:47 PM
NCT ID:
NCT03531151
Eligibility Criteria:
Inclusion Criteria:
* Between the ages of 18 and 80
* Patients must be able to read and understand English
* Participants must sign the informed consent form
* Elevated and delayed peak creatine kinase-MB and troponin I (cTnI) and troponin T (cTnT) in blood serum,
* ST elevation detected on ECG
Exclusion Criteria:
* contraindications to cardiac MRI, including claustrophobia
* advanced renal disease (estimated glomerular filtration rate 30 mL/min) or hypersensitivity to gadolinium
* presence of a cardiac pacemaker or implanted cardiac cardioverter defibrillator
* pregnancy
* personal or family history of hypertrophic cardiomyopathy
* inability to provide informed consent
* history of seizure disorder
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT03531151
Study Brief:
Protocol Section:
NCT03531151